Andrew Schwendenman's most recent trade in Replimune Group Inc was a trade of 3,287 Common Stock done at an average price of $8.0 . Disclosure was reported to the exchange on May 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Replimune Group Inc | Andrew Schwendenman | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 8.05 per share. | 20 May 2025 | 3,287 | 68,284 (0%) | 0% | 8.0 | 26,460 | Common Stock |
| Replimune Group Inc | Andrew Schwendenman | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Replimune Group Inc | Andrew Schwendenman | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 33,333 | 71,571 (0%) | 0% | 0 | Common Stock | |
| Replimune Group Inc | Andrew Schwendenman | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 16 May 2024 | 2,298 | 38,238 (0%) | 0% | 6.5 | 14,868 | Common Stock |
| Replimune Group Inc | Andrew Schwendenman | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 53,325 | 53,325 | - | - | Employee Stock Option (right to buy) | |
| Replimune Group Inc | Andrew Schwendenman | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 17,775 | 40,536 (0%) | 0% | 0 | Common Stock |